Deep-Track-Capital-Lp

AI_NATIVE detailed information: This accession holds the following tickers:[
  "OCUL",
  "AKRO",
  "EWTX",
  "INSM",
  "APLS",
  "ANIP",
  "ABVX",
  "GLPG",
  "DVAX",
  "NVAX",
  "BCAX",
  "BCYC",
  "OLMA",
  "GPCR",
  "RAPP",
  "TERN",
  "NRIX",
  "MNMD",
  "TECX",
  "NGNE",
  "SAGE",
  "ALGS",
  "ALLK",
  "AVTX",
  "GERN",
  "SYRE",
  "AUTL",
  "TARS",
  "GH",
  "IVVD",
  "KRRO",
  null,
  null,
  "OKUR",
  "SEPN",
  "IONS",
  "CYBN",
  "GHRS",
  "ZURA",
  "AMGN",
  "UPB",
  "RAPT",
  "PTGX",
  "MBX",
  "RGLS",
  "PLRX",
  "ETNB",
  "DYN",
  "SRPT",
  null,
  null,
  "CMPS",
  "CNTX",
  "IMCR",
  "IKNA",
  "INO",
  "VRDN",
  "XENE",
  "XNCR",
  "ORKA",
  null,
  "RARE",
  "IMVT",
  "PCVX",
  "BEAM",
  "BBIO",
  "CLDX",
  "CYTK",
  "DNTH"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 69
Total Value: 3088173822
Accession Number: 0001856083-25-000002
Form Type: 13F-HR
CIK: deep-track-capital-lp
Manager Name: Deep-Track-Capital-Lp

Data Enrichment

93% identified

64 identified5 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

69 positions • $3.1B total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 2 of 4

Sort by:

Dianthus Therapeutics, Inc. /DE/

DNTH|252828108

Shares:2.4M

Value:$42.8M

% of Portfolio:1.4% ($42.8M/$3.1B)

Immunocore Holdings plc

IMCR|45258D105

Shares:1.4M

Value:$41.9M

% of Portfolio:1.4% ($41.9M/$3.1B)

Celldex Therapeutics, Inc.

CLDX|15117B202

Shares:2.0M

Value:$36.3M

% of Portfolio:1.2% ($36.3M/$3.1B)

578784100

Shares:3.3M

Value:$36.0M

% of Portfolio:1.2% ($36.0M/$3.1B)

AMGEN INC

AMGN|031162100

Shares:113.0K

Value:$35.2M

% of Portfolio:1.1% ($35.2M/$3.1B)

Xenon Pharmaceuticals Inc.

XENE|98420N105

Shares:1.0M

Value:$33.5M

% of Portfolio:1.1% ($33.5M/$3.1B)

Edgewise Therapeutics, Inc.

EWTX|28036F105

Shares:1.4M

Value:$30.8M

% of Portfolio:1.0% ($30.8M/$3.1B)

59267L107

Shares:1.1M

Value:$29.8M

% of Portfolio:1.0% ($29.8M/$3.1B)

Vaxcyte, Inc.

PCVX|92243G108

Shares:750.0K

Value:$28.3M

% of Portfolio:0.9% ($28.3M/$3.1B)

Autolus Therapeutics plc

AUTL|05280R100

Shares:17.8M

Value:$27.7M

% of Portfolio:0.9% ($27.7M/$3.1B)

Bicara Therapeutics Inc.

BCAX|055477103

Shares:2.0M

Value:$26.1M

% of Portfolio:0.8% ($26.1M/$3.1B)

COMPASS Pathways plc

CMPS|20451W101

Shares:8.9M

Value:$25.3M

% of Portfolio:0.8% ($25.3M/$3.1B)

Tectonic Therapeutic, Inc.

TECX|878972108

Shares:1.4M

Value:$24.8M

% of Portfolio:0.8% ($24.8M/$3.1B)

Abivax S.A.

ABVX|00370M103

Shares:3.6M

Value:$22.4M

% of Portfolio:0.7% ($22.4M/$3.1B)

MBX Biosciences, Inc.

MBX|55287L101

Shares:3.0M

Value:$22.3M

% of Portfolio:0.7% ($22.3M/$3.1B)

GH Research PLC

GHRS|G3855L106

Shares:2.0M

Value:$22.1M

% of Portfolio:0.7% ($22.1M/$3.1B)

Dyne Therapeutics, Inc.

DYN|26818M108

Shares:2.0M

Value:$20.9M

% of Portfolio:0.7% ($20.9M/$3.1B)

29286M105

Shares:4.6M

Value:$20.4M

% of Portfolio:0.7% ($20.4M/$3.1B)

INSMED Inc

INSM|457669307

Shares:254.8K

Value:$19.4M

% of Portfolio:0.6% ($19.4M/$3.1B)

GALAPAGOS NV

GLPG|36315X101

Shares:741.1K

Value:$18.6M

% of Portfolio:0.6% ($18.6M/$3.1B)

Instrument	Shares		Other Manager	Value	% of Portfolio
Dianthus Therapeutics, Inc. /DE/(DNTHcusip252828108)	2.4M	QoQ NEW(+2.4M) YoY NEW(+2.4M)	All Managers (Combined)	$42.8M	1.4% ($42.8M/$3.1B)	QoQ NEW(+$42.8M) YoY NEW(+$42.8M)
Immunocore Holdings plc(IMCRcusip45258D105)	1.4M	QoQ +171.74% (+892.0K) YoY NEW(+1.4M)	All Managers (Combined)	$41.9M	1.4% ($41.9M/$3.1B)	QoQ +173.31% (+$26.6M) YoY NEW(+$41.9M)
Celldex Therapeutics, Inc.(CLDXcusip15117B202)	2.0M	QoQ +29.85% (-459.9K) YoY NEW(+2.0M)	All Managers (Combined)	$36.3M	1.2% ($36.3M/$3.1B)	QoQ -6.72% (-$2.6M) YoY NEW(+$36.3M)
(cusip578784100)✕	3.3M	QoQ NEW(+3.3M) YoY NEW(+3.3M)	All Managers (Combined)	$36.0M	1.2% ($36.0M/$3.1B)	QoQ NEW(+$36.0M) YoY NEW(+$36.0M)
AMGEN INC(AMGNcusip031162100)	113.0K	QoQ NEW(+113.0K) YoY -79.44% (-437.0K)	All Managers (Combined)	$35.2M	1.1% ($35.2M/$3.1B)	QoQ NEW(+$35.2M) YoY -77.47% (-$121.2M)
Xenon Pharmaceuticals Inc.(XENEcusip98420N105)	1.0M	QoQ +491.25% (+830.9K) YoY NEW(+1.0M)	All Managers (Combined)	$33.5M	1.1% ($33.5M/$3.1B)	QoQ +406.03% (+$26.9M) YoY NEW(+$33.5M)
Edgewise Therapeutics, Inc.(EWTXcusip28036F105)	1.4M	QoQ +97.06% (+689.6K) YoY NEW(+1.4M)	All Managers (Combined)	$30.8M	1.0% ($30.8M/$3.1B)	QoQ +62.37% (+$11.8M) YoY NEW(+$30.8M)
(cusip59267L107)✕	1.1M	QoQ NEW(+1.1M) YoY NEW(+1.1M)	All Managers (Combined)	$29.8M	1.0% ($29.8M/$3.1B)	QoQ NEW(+$29.8M) YoY NEW(+$29.8M)
Vaxcyte, Inc.(PCVXcusip92243G108)	750.0K	QoQ NEW(+750.0K) YoY NEW(+750.0K)	All Managers (Combined)	$28.3M	0.9% ($28.3M/$3.1B)	QoQ NEW(+$28.3M) YoY NEW(+$28.3M)
Autolus Therapeutics plc(AUTLcusip05280R100)	17.8M	QoQ +25.53% (-3.6M) YoY +16.87% (-2.6M)	All Managers (Combined)	$27.7M	0.9% ($27.7M/$3.1B)	QoQ -17.20% (-$5.7M) YoY -71.60% (-$69.8M)
Bicara Therapeutics Inc.(BCAXcusip055477103)	2.0M	QoQ 0.00% (-0) YoY NEW(+2.0M)	All Managers (Combined)	$26.1M	0.8% ($26.1M/$3.1B)	QoQ -25.20% (-$8.8M) YoY NEW(+$26.1M)
COMPASS Pathways plc(CMPScusip20451W101)	8.9M	QoQ NEW(+8.9M) YoY NEW(+8.9M)	All Managers (Combined)	$25.3M	0.8% ($25.3M/$3.1B)	QoQ NEW(+$25.3M) YoY NEW(+$25.3M)
Tectonic Therapeutic, Inc.(TECXcusip878972108)	1.4M	QoQ NEW(+1.4M) YoY NEW(+1.4M)	All Managers (Combined)	$24.8M	0.8% ($24.8M/$3.1B)	QoQ NEW(+$24.8M) YoY NEW(+$24.8M)
Abivax S.A.(ABVXcusip00370M103)	3.6M	QoQ 0.00% (-0) YoY -16.71% (-718.2K)	All Managers (Combined)	$22.4M	0.7% ($22.4M/$3.1B)	QoQ -14.61% (-$3.8M) YoY -63.59% (-$39.1M)
MBX Biosciences, Inc.(MBXcusip55287L101)	3.0M	QoQ 0.00% (-0) YoY NEW(+3.0M)	All Managers (Combined)	$22.3M	0.7% ($22.3M/$3.1B)	QoQ -59.95% (-$33.4M) YoY NEW(+$22.3M)
GH Research PLC(GHRScusipG3855L106)	2.0M	QoQ NEW(+2.0M) YoY NEW(+2.0M)	All Managers (Combined)	$22.1M	0.7% ($22.1M/$3.1B)	QoQ NEW(+$22.1M) YoY NEW(+$22.1M)
Dyne Therapeutics, Inc.(DYNcusip26818M108)	2.0M	QoQ 0.00% (-0) YoY -56.09% (-2.6M)	All Managers (Combined)	$20.9M	0.7% ($20.9M/$3.1B)	QoQ -55.60% (-$26.2M) YoY -83.82% (-$108.4M)
(cusip29286M105)✕	4.6M	QoQ 0.00% (-0) YoY +102.55% (-2.3M)	All Managers (Combined)	$20.4M	0.7% ($20.4M/$3.1B)	QoQ -32.63% (-$9.9M) YoY -46.46% (-$17.7M)
INSMED Inc(INSMcusip457669307)	254.8K	QoQ NEW(+254.8K) YoY -94.67% (-4.5M)	All Managers (Combined)	$19.4M	0.6% ($19.4M/$3.1B)	QoQ NEW(+$19.4M) YoY -85.02% (-$110.3M)
GALAPAGOS NV(GLPGcusip36315X101)	741.1K	QoQ -5.08% (-39.7K) YoY NEW(+741.1K)	All Managers (Combined)	$18.6M	0.6% ($18.6M/$3.1B)	QoQ -13.30% (-$2.9M) YoY NEW(+$18.6M)